Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Andreoletti, L; Lescieux, A; Lambert, V; Si-Mohamed, A; Matta, M; Wattre, P; Belec, L
   Semiquantitative detection of JCV-DNA in peripheral blood leukocytes from HIV-1-Infected patients with or without Progressive Multifocal Leukoencephalopathy
   JOURNAL OF MEDICAL VIROLOGY
   
   L. Andreoletti et al., "Semiquantitative detection of JCV-DNA in peripheral blood leukocytes from HIV-1-Infected patients with or without Progressive Multifocal Leukoencephalopathy", J MED VIROL, 66(1), 2002, pp. 1-7
2. Idilman, R; Cetinkaya, H; Savas, I; Aslan, N; Sak, SD; Bastemir, M; Sarioglu, M; Soykan, I; Bozdayi, M; Colantoni, A; Aydmtug, O; Bahar, K; Uzunalimoglu, O; Van Thiel, DH; Numanoglu, N; Dokmeci, A
   Bronchoalveolar lavage fluid analysis in individuals with chronic hepatitis C
   JOURNAL OF MEDICAL VIROLOGY
   
   R. Idilman et al., "Bronchoalveolar lavage fluid analysis in individuals with chronic hepatitis C", J MED VIROL, 66(1), 2002, pp. 34-39
3. Holtappels, R; Thomas, D; Podlech, J; Reddehase, MJ
   Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2(d) haplotype
   JOURNAL OF VIROLOGY
   
   R. Holtappels et al., "Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2(d) haplotype", J VIROLOGY, 76(1), 2002, pp. 151-164
4. Zaharopoulos, P
   Serous fluid cytology as a means of detecting hemophagocytosis in Epstein-Barr virus-induced autoimmune hemolytic anemia
   DIAGNOSTIC CYTOPATHOLOGY
   
   P. Zaharopoulos, "Serous fluid cytology as a means of detecting hemophagocytosis in Epstein-Barr virus-induced autoimmune hemolytic anemia", DIAGN CYTOP, 25(4), 2001, pp. 248-252
5. Solomon, RK; Lundeen, SJ; Hamlar, DD; Pambuccian, SE
   Fine-needle aspiration diagnosis of unusual cutaneous neoplasms of the scalp in HIV-infected patients: A report of two cases and review of the literature
   DIAGNOSTIC CYTOPATHOLOGY
   
   R.K. Solomon et al., "Fine-needle aspiration diagnosis of unusual cutaneous neoplasms of the scalp in HIV-infected patients: A report of two cases and review of the literature", DIAGN CYTOP, 24(3), 2001, pp. 186-192
6. Lavy, A; Broide, E; Reif, S; Keter, D; Niv, Y; Odes, S; Eliakim, R; Halak, A; Ron, Y; Patz, J; Fich, A; Villa, Y; Arber, N; Gilat, T
   Measles is more prevalent in Crohn's disease patients. A multicentre Israeli study
   DIGESTIVE AND LIVER DISEASE
   
   A. Lavy et al., "Measles is more prevalent in Crohn's disease patients. A multicentre Israeli study", DIG LIVER D, 33(6), 2001, pp. 472-476
7. Mazzoran, L; Zorat, F; Chemello, L; Croce, LS; Rigato, I; Cavalletto, L; Bernardinello, E; Tiribelli, C; Alberti, A; Pozzato, G
   Human leucocyte interferon-alpha in the treatment of chronic hepatitis C
   DIGESTIVE AND LIVER DISEASE
   
   L. Mazzoran et al., "Human leucocyte interferon-alpha in the treatment of chronic hepatitis C", DIG LIVER D, 33(4), 2001, pp. 347-352
8. Morisco, F; Mazziotti, G; Rotondi, M; Tuccillo, C; Iasevoli, P; Del Buono, A; Sorvillo, F; Amato, G; Marmo, R; Caporaso, N; Carella, C
   Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C
   DIGESTIVE AND LIVER DISEASE
   
   F. Morisco et al., "Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C", DIG LIVER D, 33(3), 2001, pp. 247-253
9. Coussons-Read, ME; Giese, S
   Acute morphine treatment alters cellular immune function in the lungs of healthy rats
   INTERNATIONAL IMMUNOPHARMACOLOGY
   
   M.E. Coussons-Read e S. Giese, "Acute morphine treatment alters cellular immune function in the lungs of healthy rats", INT IMMUNO, 1(8), 2001, pp. 1571-1581
10. Azuma, I; Seya, T
    Development of immunoadjuvants for immunotherapy of cancer
    INTERNATIONAL IMMUNOPHARMACOLOGY
    
    I. Azuma e T. Seya, "Development of immunoadjuvants for immunotherapy of cancer", INT IMMUNO, 1(7), 2001, pp. 1249-1259
11. Gilboa, E
    The risk of autoimmunity associated with tumor immunotherapy
    NATURE IMMUNOLOGY
    
    E. Gilboa, "The risk of autoimmunity associated with tumor immunotherapy", NAT IMMUNOL, 2(9), 2001, pp. 789-792
12. Wandstrat, A; Wakeland, E
    The genetics of complex autoimmune diseases: non-MHC susceptibility genes
    NATURE IMMUNOLOGY
    
    A. Wandstrat e E. Wakeland, "The genetics of complex autoimmune diseases: non-MHC susceptibility genes", NAT IMMUNOL, 2(9), 2001, pp. 802-809
13. Andrews, DM; Andoniou, CE; Granucci, F; Ricciardi-Castagnoli, P; Degli-Esposti, MA
    Infection of dendritic cells by murine cytomegalovirus induces functional paralysis
    NATURE IMMUNOLOGY
    
    D.M. Andrews et al., "Infection of dendritic cells by murine cytomegalovirus induces functional paralysis", NAT IMMUNOL, 2(11), 2001, pp. 1077-1084
14. Ong, J; Younossi, ZM; Reddy, V; Price, LL; Gramlich, T; Mayes, J; Boparai, N
    Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease
    LIVER TRANSPLANTATION
    
    J. Ong et al., "Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease", LIVER TRANS, 7(9), 2001, pp. 797-801
15. Chu, CJ; Fontana, RJ; Moore, C; Armstrong, DR; Punch, JD; Su, GL; Magee, JC; Merion, RM; Lok, ASF
    Outcome of liver transplantation for hepatitis B: Report of a single center's experience
    LIVER TRANSPLANTATION
    
    C.J. Chu et al., "Outcome of liver transplantation for hepatitis B: Report of a single center's experience", LIVER TRANS, 7(8), 2001, pp. 724-731
16. Rizzetto, M
    Transmission of hepatitis B infection from hepatitis B core antibody-positive livers: Background and prevention
    LIVER TRANSPLANTATION
    
    M. Rizzetto, "Transmission of hepatitis B infection from hepatitis B core antibody-positive livers: Background and prevention", LIVER TRANS, 7(6), 2001, pp. 518-520
17. Arslan, M; Wiesner, RH; Sievers, C; Egan, K; Zein, NN
    Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease
    LIVER TRANSPLANTATION
    
    M. Arslan et al., "Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease", LIVER TRANS, 7(4), 2001, pp. 314-320
18. Gopal, DV; Rabkin, JM; Berk, BS; Corless, CL; Chou, SW; Olyaei, A; Orloff, SL; Rosen, HR
    Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin
    LIVER TRANSPLANTATION
    
    D.V. Gopal et al., "Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin", LIVER TRANS, 7(3), 2001, pp. 181-190
19. Pastacaldi, S; Teixeira, R; Montalto, P; Rolles, K; Burroughs, AK
    Hepatic artery thrombosis after orthotopic liver transplantation: A reviewof nonsurgical causes
    LIVER TRANSPLANTATION
    
    S. Pastacaldi et al., "Hepatic artery thrombosis after orthotopic liver transplantation: A reviewof nonsurgical causes", LIVER TRANS, 7(2), 2001, pp. 75-81
20. Seehofer, D; Rayes, N; Steinmuller, T; Muller, AR; Settmacher, U; Neuhaus, R; Radke, C; Berg, T; Hopf, U; Neuhaus, P
    Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation
    LIVER TRANSPLANTATION
    
    D. Seehofer et al., "Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation", LIVER TRANS, 7(11), 2001, pp. 976-982
21. Ahmad, J; Dodson, SF; Demetris, AJ; Fung, JJ; Shakil, AO
    Recurrent hepatitis C after liver transplantation: A nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin
    LIVER TRANSPLANTATION
    
    J. Ahmad et al., "Recurrent hepatitis C after liver transplantation: A nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin", LIVER TRANS, 7(10), 2001, pp. 863-869
22. Alberti, AB; Belli, LS; Airoldi, A; de Carlis, L; Rondinara, G; Minola, E; Vangeli, M; Cernuschi, A; D'Amico, M; Forti, D; Pinzello, G
    Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: A pragmatic study
    LIVER TRANSPLANTATION
    
    A.B. Alberti et al., "Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: A pragmatic study", LIVER TRANS, 7(10), 2001, pp. 870-876
23. Kim, YJ; Broxmeyer, HE
    Therapeutic potential of 4-1BB (CD137) as a regulator for effector CD8(+) T cells
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    
    Y.J. Kim e H.E. Broxmeyer, "Therapeutic potential of 4-1BB (CD137) as a regulator for effector CD8(+) T cells", J HEMATH ST, 10(4), 2001, pp. 441-449
24. Gerna, G; Piccinini, G; Genini, E; Percivalle, E; Zavattoni, M; Lilleri, D; Testa, L; Comolli, G; Maserati, T; Baldanti, F; Maccario, R; Monforte, AD; Revello, MG
    Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    G. Gerna et al., "Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART", J ACQ IMM D, 28(4), 2001, pp. 320-331
25. Hsu, LC; Vittinghoff, E; Katz, MH; Schwarcz, SK
    Predictors of use of highly active antiretroviral therapy (HAART) among persons with AIDS in San Francisco, 1996-1999
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    L.C. Hsu et al., "Predictors of use of highly active antiretroviral therapy (HAART) among persons with AIDS in San Francisco, 1996-1999", J ACQ IMM D, 28(4), 2001, pp. 345-350
26. Knobel, H; Miro, TM; Domingo, P; Rivero, A; Marquez, M; Force, L; Gonzalez, A; De Miguel, V; Sanz, J; Boix, V; Blanco, JL; Locutura, J
    Failure of a short-term prednisone regimen to prevent nevirapine-associated rash: A double-blind placebo- controlled trial: The GESIDA 09/99 study
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    H. Knobel et al., "Failure of a short-term prednisone regimen to prevent nevirapine-associated rash: A double-blind placebo- controlled trial: The GESIDA 09/99 study", J ACQ IMM D, 28(1), 2001, pp. 14-18
27. Tozzi, V; Balestra, T; Galgani, S; Narciso, P; Sampaolesi, A; Antinori, A; Giulianelli, M; Serraino, I; Ippolito, G
    Changes in neurocognitive performance in a cohort of patients treated withHAART for 3 years
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    V. Tozzi et al., "Changes in neurocognitive performance in a cohort of patients treated withHAART for 3 years", J ACQ IMM D, 28(1), 2001, pp. 19-27
28. Fleishman, JA; Hellinger, FJ
    Trends in HIV-related inpatient admissions from 1993 to 1997: A seven-state study
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    J.A. Fleishman e F.J. Hellinger, "Trends in HIV-related inpatient admissions from 1993 to 1997: A seven-state study", J ACQ IMM D, 28(1), 2001, pp. 73-80
29. Rey, D; Schmitt, MP; Partisani, M; Hess-Kempf, G; Krantz, W; de Mautort, E; Bernard-Henry, C; Priester, M; Cheneau, C; Lang, JM
    Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: A median follow-up of 64 weeks
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    D. Rey et al., "Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: A median follow-up of 64 weeks", J ACQ IMM D, 27(5), 2001, pp. 459-462
30. Easterbrook, PJ; Newson, R; Ives, N; Pereira, S; Moyle, G; Gazzard, BG
    Comparison of virologic, immunologic, and clinical response to five different initial protease inhibitor-containing and nevirapine-containing regimens
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    P.J. Easterbrook et al., "Comparison of virologic, immunologic, and clinical response to five different initial protease inhibitor-containing and nevirapine-containing regimens", J ACQ IMM D, 27(4), 2001, pp. 350-364
31. Duong, M; Petit, JM; Piroth, L; Grappin, M; Buisson, M; Chavanet, P; Hillon, S; Portier, H
    Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviraltherapy
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    M. Duong et al., "Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviraltherapy", J ACQ IMM D, 27(3), 2001, pp. 245-250
32. Lucas, GM; Cheever, LW; Chaisson, RE; Moore, RD
    Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    G.M. Lucas et al., "Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection", J ACQ IMM D, 27(3), 2001, pp. 251-259
33. Bijl, M; Dieleman, JP; Simoons, M; van der Ende, ME
    Low prevalence of cardiac abnormalities in an HIV-seropositive population on antiretroviral combination therapy
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    M. Bijl et al., "Low prevalence of cardiac abnormalities in an HIV-seropositive population on antiretroviral combination therapy", J ACQ IMM D, 27(3), 2001, pp. 318-320
34. Nicholson, JKA; Browning, SW; Hengel, RL; Lew, E; Gallagher, LE; Rimland, D; McDougal, JS
    CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    J.K.A. Nicholson et al., "CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy", J ACQ IMM D, 27(2), 2001, pp. 105-115
35. Ungsedhapand, C; Kroon, EDMB; Suwanagool, S; Ruxrungtham, K; Yimsuan, N; Sonjai, A; Ubolyam, S; Buranapraditkun, S; Tiengrim, S; Pakker, N; Kunanusont, C; Lange, JMA; Cooper, DA; Phanuphak, P
    A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    C. Ungsedhapand et al., "A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients", J ACQ IMM D, 27(2), 2001, pp. 116-123
36. Cotten-Oldenburg, NU; Carr, P; DeBoer, JM; Collison, EK; Novotny, G
    Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    N.U. Cotten-Oldenburg et al., "Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999", J ACQ IMM D, 27(2), 2001, pp. 183-192
37. Keiser, P; Nassar, N; Kvanli, MB; Turner, D; Smith, JW; Skiest, D
    Long-term impact of highly active antiretroviral therapy on HIV-related health care costs
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    P. Keiser et al., "Long-term impact of highly active antiretroviral therapy on HIV-related health care costs", J ACQ IMM D, 27(1), 2001, pp. 14-19
38. Thorpe, LE; Bailey, SL; Huo, DZ; Monterroso, ER; Ouellet, LJ
    Injection-related risk behaviors in young urban and suburban injection drug users in Chicago (1997-1999)
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    L.E. Thorpe et al., "Injection-related risk behaviors in young urban and suburban injection drug users in Chicago (1997-1999)", J ACQ IMM D, 27(1), 2001, pp. 71-78
39. Funk, GA; Fischer, M; Joos, B; Opravil, M; Gunthard, HF; Ledergerber, B; Bonhoeffer, S
    Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    G.A. Funk et al., "Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells", J ACQ IMM D, 26(5), 2001, pp. 397-404
40. Adje, C; Cheingsong, R; Roels, TH; Maurice, C; Djomand, G; Verbiest, W; Hertogs, K; Larder, B; Monga, B; Peeters, M; Eholie, S; Bissagene, E; Coulibaly, M; Respess, R; Wiktor, SZ; Chorba, T; Nkengasong, JN
    High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Cote d'Ivoire
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    C. Adje et al., "High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Cote d'Ivoire", J ACQ IMM D, 26(5), 2001, pp. 501-506
41. Semba, RD; Shah, N; Vlahov, D
    Improvement of anemia among HIV-infected injection drug users receiving highly active antiretroviral therapy
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    R.D. Semba et al., "Improvement of anemia among HIV-infected injection drug users receiving highly active antiretroviral therapy", J ACQ IMM D, 26(4), 2001, pp. 315-319
42. Girardi, E; Palmieri, F; Cingolani, A; Ammassari, A; Petrosillo, N; Gillini, L; Zinzi, D; De Luca, A; Antinori, A; Ippolito, G
    Changing clinical presentation and survival in HIV-associated tuberculosisafter highly active antiretroviral therapy
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    E. Girardi et al., "Changing clinical presentation and survival in HIV-associated tuberculosisafter highly active antiretroviral therapy", J ACQ IMM D, 26(4), 2001, pp. 326-331
43. Kost, RG; Hurley, A; Zhang, LQ; Vesanen, M; Talal, A; Furlan, S; Caldwell, P; Johnson, J; Smiley, L; Ho, D; Markowitz, M
    Open-label phase II trial of amprenavir, abacavir, and fixed-dose zidovudine/lamivudine in newly and chronically HIV-1-infected patients
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    R.G. Kost et al., "Open-label phase II trial of amprenavir, abacavir, and fixed-dose zidovudine/lamivudine in newly and chronically HIV-1-infected patients", J ACQ IMM D, 26(4), 2001, pp. 332-339
44. Lai, S; Liu, W; Chen, J; Yang, J; Li, ZJ; Li, RJ; Liang, FX; Liang, SL; Zhu, QY; Yu, XF
    Changes in HIV-1 incidence in heroin users in Guangxi Province, China
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    S. Lai et al., "Changes in HIV-1 incidence in heroin users in Guangxi Province, China", J ACQ IMM D, 26(4), 2001, pp. 365-370
45. Biggar, RJ; Engels, EA; Frisch, M; Goedert, JJ
    Risk of T-cell lymphomas in persons with AIDS
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    R.J. Biggar et al., "Risk of T-cell lymphomas in persons with AIDS", J ACQ IMM D, 26(4), 2001, pp. 371-376
46. Dore, GJ; Li, YM; McDonald, A; Kaldor, JM
    Spectrum of AIDS-defining illnesses in Australia, 1992 to 1998: Influence of country/region of birth
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    G.J. Dore et al., "Spectrum of AIDS-defining illnesses in Australia, 1992 to 1998: Influence of country/region of birth", J ACQ IMM D, 26(3), 2001, pp. 283-290
47. Levine, AM; Berhane, K; Masri-Lavine, L; Sanchez, ML; Young, M; Augenbraun, M; Cohen, M; Anastos, K; Newman, M; Gange, SJ; Watts, H
    Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women's interagency HIV study
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    A.M. Levine et al., "Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women's interagency HIV study", J ACQ IMM D, 26(1), 2001, pp. 28-35
48. Green, MJ; Fong, S; Mauger, DT; Ubel, PA
    Rationing HIV medications: What do patients and the public think about allocation policies?
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    M.J. Green et al., "Rationing HIV medications: What do patients and the public think about allocation policies?", J ACQ IMM D, 26(1), 2001, pp. 56-62
49. Bovolenta, C; Camorali, L; Mauri, M; Ghezzi, S; Nozza, S; Tambussi, G; Lazzarin, A; Poli, G
    Expression and activation of a C-terminal truncated isoform of STAT5 (STAT5 Delta) following interleukin 2 administration or AZT monotherapy in HIV-infected individuals
    CLINICAL IMMUNOLOGY
    
    C. Bovolenta et al., "Expression and activation of a C-terminal truncated isoform of STAT5 (STAT5 Delta) following interleukin 2 administration or AZT monotherapy in HIV-infected individuals", CLIN IMMUNO, 99(1), 2001, pp. 75-81
50. Anderson, DE; Carlos, MP; Nguyen, L; Torres, JV
    Overcoming original (antigenic) sin
    CLINICAL IMMUNOLOGY
    
    D.E. Anderson et al., "Overcoming original (antigenic) sin", CLIN IMMUNO, 101(2), 2001, pp. 152-157
51. Dyrhol-Riise, AM; Ohlsson, M; Skarstein, K; Nygaard, SJT; Olofsson, J; Jonsson, R; Asjo, B
    T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: Impact of highly active antiretroviral therapy
    CLINICAL IMMUNOLOGY
    
    A.M. Dyrhol-Riise et al., "T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: Impact of highly active antiretroviral therapy", CLIN IMMUNO, 101(2), 2001, pp. 180-191
52. Marone, G; Florio, G; Petraroli, A; Triggiani, M; de Paulis, A
    Human mast cells and basophils in HIV-1 infection
    TRENDS IN IMMUNOLOGY
    
    G. Marone et al., "Human mast cells and basophils in HIV-1 infection", TRENDS IMMU, 22(5), 2001, pp. 229-232
53. Montaner, LJ
    Structured treatment interruptions to control HIV-1 and limit drug exposure
    TRENDS IN IMMUNOLOGY
    
    L.J. Montaner, "Structured treatment interruptions to control HIV-1 and limit drug exposure", TRENDS IMMU, 22(2), 2001, pp. 92-96
54. Chiou, HC; Lucas, MA; Coffin, CC; Banaszczyk, MG; Ill, CR; Lollo, CP
    Gene therapy strategies for the treatment of chronic viral hepatitis
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    H.C. Chiou et al., "Gene therapy strategies for the treatment of chronic viral hepatitis", EXPERT OP B, 1(4), 2001, pp. 629-639
55. Anderson, J
    Infections in HIV disease
    CLINICAL MEDICINE
    
    J. Anderson, "Infections in HIV disease", CLIN MED, 1(4), 2001, pp. 292-295
56. Bruce, IN; Silman, AJ
    The aetiology of psoriatic arthritis
    RHEUMATOLOGY
    
    I.N. Bruce e A.J. Silman, "The aetiology of psoriatic arthritis", RHEUMATOLOG, 40(4), 2001, pp. 363-366
57. Thursz, M
    MHC and the viral hepatitides
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    
    M. Thursz, "MHC and the viral hepatitides", QJM-MON J A, 94(6), 2001, pp. 287-291
58. Jowett, SL; Agarwal, K; Smith, BC; Craig, W; Hewett, M; Bassendine, DR; Gilvarry, E; Burt, AD; Basendine, MF
    Managing chronic hepatitis C acquired through intravenous drug use
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    
    S.L. Jowett et al., "Managing chronic hepatitis C acquired through intravenous drug use", QJM-MON J A, 94(3), 2001, pp. 153-158
59. Ostapowicz, G; Dallinger, M; Bell, SJ; Strasser, SI; Watson, KJR; Slavin, J; Santamaria, J; Desmond, PV
    Changes in hepatitis C-related liver disease in a large clinic population
    INTERNAL MEDICINE JOURNAL
    
    G. Ostapowicz et al., "Changes in hepatitis C-related liver disease in a large clinic population", INTERN M J, 31(2), 2001, pp. 90-96
60. Rossi, M; Flepp, M; Telenti, A; Schiffer, V; Egloff, N; Bucher, H; Vernazza, P; Bernasconi, E; Weber, R; Rickenbach, M; Furrer, H
    Disseminated M-avium complex infection in the Swiss HIV cohort study: Declining incidence, improved prognosis and discontinuation of maintenance therapy
    SWISS MEDICAL WEEKLY
    
    M. Rossi et al., "Disseminated M-avium complex infection in the Swiss HIV cohort study: Declining incidence, improved prognosis and discontinuation of maintenance therapy", SWISS MED W, 131(31-32), 2001, pp. 471-477
61. Moradpour, D; Cerny, A; Heim, MH; Blum, HE
    Hepatitis C: an update
    SWISS MEDICAL WEEKLY
    
    D. Moradpour et al., "Hepatitis C: an update", SWISS MED W, 131(21-22), 2001, pp. 291-298
62. Seitz, R
    Human cytomegalovirus
    INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    
    R. Seitz, "Human cytomegalovirus", INFUS THER, 28(3), 2001, pp. 165-171
63. Out, TA; de Pater-Huijsen, FL; Jansen, HM; Corrigan, CJ
    CD8 T cells: Potential therapeutic targets?
    NEW DRUGS FOR ASTHMA, ALLERGY AND COPD
    
    T.A. Out et al., "CD8 T cells: Potential therapeutic targets?", PROG R RES, 31, 2001, pp. 233-236
64. Brichard, B; Smets, F; Sokal, E; Clapuyt, P; Vermylen, C; Cornu, G; Rahier, J; Otte, JB
    Unusual evolution of an Epstein-Barr virus-associated leiomyosarcoma occurring after liver transplantation
    PEDIATRIC TRANSPLANTATION
    
    B. Brichard et al., "Unusual evolution of an Epstein-Barr virus-associated leiomyosarcoma occurring after liver transplantation", PEDIAT TRAN, 5(5), 2001, pp. 365-369
65. Tabery, HM
    Healing of recurrent herpes simplex corneal epithelial lesions treated with topical acyclovir - A non-contact photomicrographic in vivo study in the human cornea
    ACTA OPHTHALMOLOGICA SCANDINAVICA
    
    H.M. Tabery, "Healing of recurrent herpes simplex corneal epithelial lesions treated with topical acyclovir - A non-contact photomicrographic in vivo study in the human cornea", ACT OPHTH S, 79(3), 2001, pp. 256-261
66. Aarnoutse, RE; Wissen, CPWGMVV; Underberg, WJM; Kleinnijenhuis, J; Hekster, YA; Burger, DM
    High-performance liquid chromatography of HIV protease inhibitors in humanbiological matrices
    JOURNAL OF CHROMATOGRAPHY B
    
    R.E. Aarnoutse et al., "High-performance liquid chromatography of HIV protease inhibitors in humanbiological matrices", J CHROMAT B, 764(1-2), 2001, pp. 363-384
67. Mijch, AM; Hoy, J; Watson, K; Dunne, A; Crowe, S; Wesselingh, SL
    Does plasma HIV RNA predict outcome in a cohort of treated HIV-infected individuals followed over 3 years?
    JOURNAL OF CLINICAL VIROLOGY
    
    A.M. Mijch et al., "Does plasma HIV RNA predict outcome in a cohort of treated HIV-infected individuals followed over 3 years?", J CLIN VIRO, 22(3), 2001, pp. 271-278
68. Preiser, W; Brauninger, S; Schwerdtfeger, R; Ayliffe, U; Garson, JA; Brink, NS; Franck, S; Doerr, HW; Rabenau, HF
    Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants
    JOURNAL OF CLINICAL VIROLOGY
    
    W. Preiser et al., "Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants", J CLIN VIRO, 20(1-2), 2001, pp. 59-70
69. Atsukawa, K; Saito, H; Tsukada, N; Akiba, Y; Toda, K; Kumagai, N; Ohishi, T; Kamegaya, Y; Ishii, H
    Th1 and Th2 cytokines differentially regulate the transformation of Kupffer cells into multinucleated giant cells but similarly enhance the Kupffer cell-induced hepatic stellate cell proliferation
    HEPATOLOGY RESEARCH
    
    K. Atsukawa et al., "Th1 and Th2 cytokines differentially regulate the transformation of Kupffer cells into multinucleated giant cells but similarly enhance the Kupffer cell-induced hepatic stellate cell proliferation", HEPATOL RES, 20(2), 2001, pp. 193-206
70. Kato, M; Ikeda, N; Matsushita, E; Kaneko, S; Kobayashi, K
    Involvement of IL-10, an anti-inflammatory cytokine in murine liver injuryinduced by Concanavalin A
    HEPATOLOGY RESEARCH
    
    M. Kato et al., "Involvement of IL-10, an anti-inflammatory cytokine in murine liver injuryinduced by Concanavalin A", HEPATOL RES, 20(2), 2001, pp. 232-243
71. Momosaka, Y; Yamada, S; Harada, Y; Mine, S; Tsuchiya, Y; Okubo, H; Eto, S
    Change of the host immune response during the early phase of interferon therapy correlates with its long-term efficacy for chronic hepatitis C
    HEPATOLOGY RESEARCH
    
    Y. Momosaka et al., "Change of the host immune response during the early phase of interferon therapy correlates with its long-term efficacy for chronic hepatitis C", HEPATOL RES, 19(2), 2001, pp. 131-143
72. Le Monte, AM; Goldman, M; Smedema, ML; Connolly, PA; McKinsey, DS; Cloud, GA; Kauffman, CA; Wheat, LJ
    DNA fingerprinting of serial Candida albicans isolates obtained during itraconazole prophylaxis in patients with AIDS
    MEDICAL MYCOLOGY
    
    A.M. Le Monte et al., "DNA fingerprinting of serial Candida albicans isolates obtained during itraconazole prophylaxis in patients with AIDS", MED MYCOL, 39(2), 2001, pp. 207-213
73. Prikazsky, V; Bock, HL
    Higher anti-hepatitis B response with combined DTPw-HBV vaccine compared with separate administration in healthy infants at 3, 4 and 5 months of age in Slovakia
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    V. Prikazsky e H.L. Bock, "Higher anti-hepatitis B response with combined DTPw-HBV vaccine compared with separate administration in healthy infants at 3, 4 and 5 months of age in Slovakia", INT J CL PR, 55(3), 2001, pp. 156-161
74. Wallace, MR; Nelson, JA; McCutchan, JA; Wolfson, T; Grant, I
    Symptomatic HIV seroconverting illness is associated with more rapid neurological impairment
    SEXUALLY TRANSMITTED INFECTIONS
    
    M.R. Wallace et al., "Symptomatic HIV seroconverting illness is associated with more rapid neurological impairment", SEX TRANS I, 77(3), 2001, pp. 199-201
75. Nieuwkerk, P; Gisolf, E; Sprangers, M; Danner, S
    Adherence over 48 weeks in an antiretroviral clinical trial: variable within patients, affected by toxicities and independently predictive of virological response
    ANTIVIRAL THERAPY
    
    P. Nieuwkerk et al., "Adherence over 48 weeks in an antiretroviral clinical trial: variable within patients, affected by toxicities and independently predictive of virological response", ANTIVIR TH, 6(2), 2001, pp. 97-103
76. McMahon, D; Lederman, M; Haas, DW; Haubrich, R; Stanford, J; Cooney, E; Horton, J; Kelleher, D; Ross, L; Cutrell, A; Lee, D; Spreen, W; Mellors, JW
    Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adults
    ANTIVIRAL THERAPY
    
    D. McMahon et al., "Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adults", ANTIVIR TH, 6(2), 2001, pp. 105-114
77. Gartland, M
    AVANTI 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients
    ANTIVIRAL THERAPY
    
    M. Gartland, "AVANTI 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients", ANTIVIR TH, 6(2), 2001, pp. 127-134
78. Rozenbaum, W; Katlama, C; Massip, P; Bentata, M; Zucman, D; Delfraissy, JF; Trepo, C; David, F; Lanier, ER; Vavro, C; Mamet, JP
    Treatment intensification with abacavir in HIV-infected patients with at least 12 weeks previous lamivudine/zidovudine treatment
    ANTIVIRAL THERAPY
    
    W. Rozenbaum et al., "Treatment intensification with abacavir in HIV-infected patients with at least 12 weeks previous lamivudine/zidovudine treatment", ANTIVIR TH, 6(2), 2001, pp. 135-142
79. Walmsley, SL; Becker, MI; Zhang, M; Humar, A; Harrigan, PR
    Predictors of virological response in HIV-infected patients to salvage antiretroviral therapy that includes nelfinavir
    ANTIVIRAL THERAPY
    
    S.L. Walmsley et al., "Predictors of virological response in HIV-infected patients to salvage antiretroviral therapy that includes nelfinavir", ANTIVIR TH, 6(1), 2001, pp. 47-54
80. Foudraine, NA; Jurriaans, S; Weverling, GJ; Burger, DM; Hoetelmans, RMW; Roos, MTL; Maas, J; Miedema, F; Reiss, P; Portegies, P; de Wolf, F; Lange, JMA
    Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial
    ANTIVIRAL THERAPY
    
    N.A. Foudraine et al., "Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial", ANTIVIR TH, 6(1), 2001, pp. 55-62
81. Martinez-Raga, J; Marshall, EJ; Keaney, F; Best, D; Ball, D; Strang, J
    Hepatitis B and C in alcohol-dependent patients admitted to a UK alcohol inpatient treatment unit
    ADDICTION BIOLOGY
    
    J. Martinez-Raga et al., "Hepatitis B and C in alcohol-dependent patients admitted to a UK alcohol inpatient treatment unit", ADDICT BIOL, 6(4), 2001, pp. 363-372
82. Llorente, AM; Van Gorp, WG; Stern, MJ; George, L; Satz, P; Marcotte, TD; Calvillo, GM; Hinkin, CH
    Long-term effects of high-dose zidovudine treatment on neuropsychological performance in mildly symptomatic HIV-positive patients: Results of a randomized, double-blind, placebo-controlled investigation
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
    
    A.M. Llorente et al., "Long-term effects of high-dose zidovudine treatment on neuropsychological performance in mildly symptomatic HIV-positive patients: Results of a randomized, double-blind, placebo-controlled investigation", J INT NEURO, 7(1), 2001, pp. 27-32
83. Mega, H; Jiang, WW; Takagi, M
    Immunohistochemical study of oral lichen planus associated with hepatitis C virus infection, oral lichenoid contact sensitivity reaction and idiopathic oral lichen planus
    ORAL DISEASES
    
    H. Mega et al., "Immunohistochemical study of oral lichen planus associated with hepatitis C virus infection, oral lichenoid contact sensitivity reaction and idiopathic oral lichen planus", ORAL DIS, 7(5), 2001, pp. 296-305
84. Battegay, M
    Critical issues of HIV treatment in the era of highly active antiretroviral therapy
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    M. Battegay, "Critical issues of HIV treatment in the era of highly active antiretroviral therapy", EXPERT OP I, 10(2), 2001, pp. 175-183
85. Merle, P; Trepo, C
    Therapeutic management of hepatitis B-related cirrhosis
    JOURNAL OF VIRAL HEPATITIS
    
    P. Merle e C. Trepo, "Therapeutic management of hepatitis B-related cirrhosis", J VIRAL HEP, 8(6), 2001, pp. 391-399
86. Liu, J; Lin, H; McIntosh, H
    Genus Phyllanthus for chronic hepatitis B virus infection: a systematic review
    JOURNAL OF VIRAL HEPATITIS
    
    J. Liu et al., "Genus Phyllanthus for chronic hepatitis B virus infection: a systematic review", J VIRAL HEP, 8(5), 2001, pp. 358-366
87. Shehab, TM; Sonnad, SS; Lok, ASF
    Management of hepatitis C patients by primary care physicians in the USA: results of a national survey
    JOURNAL OF VIRAL HEPATITIS
    
    T.M. Shehab et al., "Management of hepatitis C patients by primary care physicians in the USA: results of a national survey", J VIRAL HEP, 8(5), 2001, pp. 377-383
88. Myers, RP; Hilsden, RJ; Lee, SS
    Historical features are poor predictors of liver fibrosis in Canadian patients with chronic hepatitis C
    JOURNAL OF VIRAL HEPATITIS
    
    R.P. Myers et al., "Historical features are poor predictors of liver fibrosis in Canadian patients with chronic hepatitis C", J VIRAL HEP, 8(4), 2001, pp. 249-255
89. Teixeira, R; Papatheodoridis, GV; Burroughs, AK
    Management of recurrent hepatitis C after liver transplantation
    JOURNAL OF VIRAL HEPATITIS
    
    R. Teixeira et al., "Management of recurrent hepatitis C after liver transplantation", J VIRAL HEP, 8(3), 2001, pp. 159-168
90. Katayama, K; Kasahara, A; Sasaki, Y; Kashiwagi, T; Naito, M; Masuzawa, M; Katoh, M; Yoshihara, H; Kamada, T; Mukuda, T; Hijioka, T; Hori, M; Hayashi, N
    Immunological response to interferon-gamma priming prior to interferon-alpha treatment in refractory chronic hepatitis C in relation to viral clearance
    JOURNAL OF VIRAL HEPATITIS
    
    K. Katayama et al., "Immunological response to interferon-gamma priming prior to interferon-alpha treatment in refractory chronic hepatitis C in relation to viral clearance", J VIRAL HEP, 8(3), 2001, pp. 180-185
91. Andreone, P; Cursaro, C; Gramenzi, A; Margotti, M; Ferri, E; Talarico, S; Biselli, M; Felline, F; Tuthill, C; Martins, E; Gasbarrini, G; Bernardi, M
    In vitro effect of thymosin-alpha 1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C
    JOURNAL OF VIRAL HEPATITIS
    
    P. Andreone et al., "In vitro effect of thymosin-alpha 1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C", J VIRAL HEP, 8(3), 2001, pp. 194-201
92. Larrea, E; Alberdi, A; Castelruiz, Y; Boya, P; Civeira, MP; Prieto, J
    Expression of interferon-alpha subtypes in peripheral mononuclear cells from patients with chronic hepatitis C: a role for interferon-alpha 5
    JOURNAL OF VIRAL HEPATITIS
    
    E. Larrea et al., "Expression of interferon-alpha subtypes in peripheral mononuclear cells from patients with chronic hepatitis C: a role for interferon-alpha 5", J VIRAL HEP, 8(2), 2001, pp. 103-110
93. Clarysse, C; Lin, L; Crabbe, T; van Pelt, JF; Cammack, N; Yap, SH
    HVR1 quasispecies analysis from a long-term culture of hepatitis C virus in Hep G2 derived cells grown in a haemodialysis cartridge
    JOURNAL OF VIRAL HEPATITIS
    
    C. Clarysse et al., "HVR1 quasispecies analysis from a long-term culture of hepatitis C virus in Hep G2 derived cells grown in a haemodialysis cartridge", J VIRAL HEP, 8(2), 2001, pp. 132-138
94. Gursoy, M; Gur, G; Arslan, H; Ozdemir, N; Boyacioglu, S
    Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment
    JOURNAL OF VIRAL HEPATITIS
    
    M. Gursoy et al., "Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment", J VIRAL HEP, 8(1), 2001, pp. 70-77
95. La Spina, I; Porazzi, D; Maggiolo, F; Bottura, P; Suter, F
    Gabapentin in painful HIV-related neuropathy: a report of 19 patients, preliminary observations
    EUROPEAN JOURNAL OF NEUROLOGY
    
    I. La Spina et al., "Gabapentin in painful HIV-related neuropathy: a report of 19 patients, preliminary observations", EUR J NEUR, 8(1), 2001, pp. 71-75
96. Glas, C; Hotz, P; Steffen, R
    Hepatitis A in workers exposed to sewage: a systematic review
    OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
    
    C. Glas et al., "Hepatitis A in workers exposed to sewage: a systematic review", OCC ENVIR M, 58(12), 2001, pp. 762-768
97. Aihara, Y; Katakura, S; Imagawa, T; Mitsuda, T; Yokota, S
    Transient remission of intractable systemic-type of juvenile rheumatoid arthritis after chickenpox in a 2-year-old boy
    PEDIATRICS INTERNATIONAL
    
    Y. Aihara et al., "Transient remission of intractable systemic-type of juvenile rheumatoid arthritis after chickenpox in a 2-year-old boy", PEDIATR INT, 43(1), 2001, pp. 95-97
98. Trasancos, CC; Kainer, MA; Desmond, PV; Kelly, H
    Investigation of potential iatrogenic transmission of hepatitis C in Victoria, Australia
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH
    
    C.C. Trasancos et al., "Investigation of potential iatrogenic transmission of hepatitis C in Victoria, Australia", AUS NZ J PU, 25(3), 2001, pp. 241-244
99. Mills, KHG
    Immunity to Bordetella pertussis
    MICROBES AND INFECTION
    
    K.H.G. Mills, "Immunity to Bordetella pertussis", MICROBES IN, 3(8), 2001, pp. 655-677
100. Karp, CL; Wills-Karp, M
     Complement and IL-12: yin and yang
     MICROBES AND INFECTION
     
     C.L. Karp e M. Wills-Karp, "Complement and IL-12: yin and yang", MICROBES IN, 3(2), 2001, pp. 109-119